Prime Therapeutics
Brenda Nelson is a highly experienced clinical pharmacy professional currently serving as the Clinical Program Development Director and Principal Clinical Program Pharmacist for Formulary Development at Prime Therapeutics since November 2017. Brenda has a strong background in formulary development, clinical consultation for Medicare Part D and Medicaid, and has contributed significantly as the secretary of the national P&T Committee. Previous roles include Clinical Pharmacy Manager at Allina Health, where Brenda managed a team and led various drug use improvement initiatives, and Clinical Pharmacist at Blue Cross and Blue Shield of Minnesota, focusing on quality improvement in medication use for Medicare Advantage members. Brenda's experience extends to academia as an adjunct professor at St. Catherine University, and includes significant contributions in clinical settings, such as directing clinical practice guidelines at Hennepin Healthcare. Educational credentials include a Doctor of Pharmacy from the University of Minnesota and advanced certificates from Harvard Medical School in immunology and immuno-oncology.
Prime Therapeutics
32 followers
Manages pharmacy benefits for health plans, employers and government programs, including Medicare and Medicaid. It also processes claims and delivers medicine to members, offering clinical services for people with complex medical conditions.